Wan X, Wang D, Zhang X, Xu M, Huang Y, Qin W
Int J Oncol. 2025; 66(3).
PMID: 39917986
PMC: 11837902.
DOI: 10.3892/ijo.2025.5724.
Hu J, Zhang J, Wan S, Zhang P
Chin Med J Pulm Crit Care Med. 2025; 2(4):224-239.
PMID: 39834585
PMC: 11742355.
DOI: 10.1016/j.pccm.2024.11.003.
Wang N, Pachai M, Li D, Lee C, Warda S, Khudoynazarova M
Nat Genet. 2025; 57(1):165-179.
PMID: 39806204
PMC: 11735410.
DOI: 10.1038/s41588-024-02015-y.
Lin Y, Wang J, Wang K, Bai S, Thennavan A, Wei R
Nature. 2024; 636(8043):663-670.
PMID: 39567687
DOI: 10.1038/s41586-024-08129-x.
Zhang J, Wang Q, Liu J, Duan Y, Liu Z, Zhang Z
Biol Direct. 2024; 19(1):112.
PMID: 39533395
PMC: 11556110.
DOI: 10.1186/s13062-024-00559-x.
Emerging strategies to investigate the biology of early cancer.
Zhou R, Tang X, Wang Y
Nat Rev Cancer. 2024; 24(12):850-866.
PMID: 39433978
DOI: 10.1038/s41568-024-00754-y.
The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution.
Nguyen D, Hooper W, Liu W, Chu T, Geiger H, Shelton J
Nature. 2024; 635(8037):219-228.
PMID: 39385020
PMC: 11541202.
DOI: 10.1038/s41586-024-07955-3.
Imposter among us: field cancerization in the bladder.
Rodden D, Chung E, Pittie R, Miyamoto D
Transl Androl Urol. 2024; 13(7):1319-1323.
PMID: 39100848
PMC: 11291423.
DOI: 10.21037/tau-24-8.
Proteogenomic insights into the biology and treatment of pan-melanoma.
Xiang H, Luo R, Wang Y, Yang B, Xu S, Huang W
Cell Discov. 2024; 10(1):78.
PMID: 39039072
PMC: 11263678.
DOI: 10.1038/s41421-024-00688-7.
Association of resection margin distance with anastomotic recurrence in stage I-III colon cancer: data from the National Colorectal Cancer Cohort (NCRCC) study in China.
Huang F, Jiang S, Wei R, Xiao T, Wei F, Zheng Z
Int J Colorectal Dis. 2024; 39(1):105.
PMID: 38995409
PMC: 11245431.
DOI: 10.1007/s00384-024-04684-x.
Comprehensive Collection of Whole-Slide Images and Genomic Profiles for Patients with Bladder Cancer.
Xu P, Li T, Qu F, Tian M, Wang J, Gan H
Sci Data. 2024; 11(1):699.
PMID: 38937479
PMC: 11211330.
DOI: 10.1038/s41597-024-03526-3.
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets.
Zhang S, Xiao X, Yi Y, Wang X, Zhu L, Shen Y
Signal Transduct Target Ther. 2024; 9(1):149.
PMID: 38890350
PMC: 11189549.
DOI: 10.1038/s41392-024-01848-7.
Urine Biopsy as Dynamic Biomarker to Enhance Clinical Staging of Bladder Cancer in Radical Cystectomy Candidates.
Satyal U, Valentine H, Liu D, Slifker M, Lallas C, Trabulsi E
JCO Precis Oncol. 2024; 8:e2300362.
PMID: 38865671
PMC: 11671773.
DOI: 10.1200/PO.23.00362.
Single-cell transcriptomic landscape and the microenvironment of normal adjacent tissues in hypopharyngeal carcinoma.
Guan R, Li C, Gu F, Li W, Wei D, Cao S
BMC Genomics. 2024; 25(1):489.
PMID: 38760729
PMC: 11100249.
DOI: 10.1186/s12864-024-10321-2.
Cumulative incidence and risk factors for recurrence of upper tract urothelial carcinoma in patients undergoing radical cystectomy.
Yamashita R, Nakamura M, Notsu A, Asakura K, Usui K, Sakura Y
BJUI Compass. 2024; 5(5):483-489.
PMID: 38751952
PMC: 11090764.
DOI: 10.1002/bco2.336.
Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis.
Lee S, Bondaruk J, Wang Y, Chen H, Lee J, Majewski T
Cell Rep. 2024; 43(5):114146.
PMID: 38676926
PMC: 11265536.
DOI: 10.1016/j.celrep.2024.114146.
Clonal expansion in normal tissues.
Maeda H, Kakiuchi N
Cancer Sci. 2024; 115(7):2117-2124.
PMID: 38623936
PMC: 11247609.
DOI: 10.1111/cas.16183.
Somatic mutations in aging and disease.
Ren P, Zhang J, Vijg J
Geroscience. 2024; 46(5):5171-5189.
PMID: 38488948
PMC: 11336144.
DOI: 10.1007/s11357-024-01113-3.
Tissue mosaicism following stem cell aging: blood as an exemplar.
Kapadia C, Goodell M
Nat Aging. 2024; 4(3):295-308.
PMID: 38438628
DOI: 10.1038/s43587-024-00589-0.
Targeting histone modifiers in bladder cancer therapy - preclinical and clinical evidence.
Zhang S, Lin T, Xiong X, Chen C, Tan P, Wei Q
Nat Rev Urol. 2024; 21(8):495-511.
PMID: 38374198
DOI: 10.1038/s41585-024-00857-z.